Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


...

DEPRECATED: Please see Data File entry for CSBC/PSON below with the rest of the portals.

This describes the 'Explore Data' table.

This is not a card, but an explore table.

Table driving this: https://www.synapse.org/#!Synapse:syn21346411/tables/

Previously used a file view to drive Explore Data: https://www.synapse.org/#!Synapse:syn9630847/tables/

The following is a brief description of the relevant columns in the table below (by column header):

portal name: name as it should appear in data portal

synapse file view column: corresponding name (e.g., for SQL query) in Synapse table view

facet: true if column_name should be faceted in data portal.


desired for CSBC/PS-ON: should this column be included in the CSBC data portal

The following annotations do not exist on file: theme

The following annotations need to be "ported" to GDC: Data Category (currently use existing "assay", but eventually use "data_category"); 

The following have been added to the synapse table, but are blank. They need to be filled in:

data_categoryracesample_type
portal namesynapse file view columnfacetconceptexampleGDC equivalentfaceted on GDCfacet on CSBCGDC referencesizerestricted valuescommentsin AMP-AD portalin NF portaldesired for CSBC/PS-ONGDC equivalentspeciesnone
File NamenamenoThe name (or part of a name) of a file (of any type).
file_namenono





TitleTitleno










Speciesspeciesyes

none
yes





ThemeThemeyes
tumor-heterogeneitynone
yes





Data CategoryNAnoBroad categorization of the contents of the data file.
  • Transcriptome Profiling
data_categoryyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)data_type

Data TypeNAnoSpecific content type of the data file.
  • Exon Expression Quantification
  • Gene Expression Quantification
  • Isoform Expression Quantification
  • Splice Junction Quantification
data_typeyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)data_format

Data FormatfileFormatyesFormat of the data files.
  • CSV
  • HDF5
  • TSV
  • TXT
  • SRA XML
  • MAGE-TAB
  • SDRF
  • IDF
  • ADF
data_formatyesexperimental_strategyyes





AssayexperimentalStrategyyesThe sequencing strategy used to generate the data file.  REMOVE "sequencing" for CSBC.
  • RNA-Seq
  • Total RNA-Seq
experimental_strategyyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

file_nameThe name (or part of a name) of a file (of any type).file_namenofile_sizesizeNAnoThe size of the data file (object) in bytes.
file_sizenono





md5sumNAnoThe 128-bit hash value expressed as a 32 digit hexadecimal number (in lower case) used as a file's digital fingerprint.
md5sumnoplatformnoplatform





PlatformyesNAworkflow_typeGeneric name for the workflow used to analyze a data set.
  • BWA
  • BWA with BQSR
  • BWA-aln
  • BWA-mem
  • BWA with Mark Duplicates and BQSR
yesdisease_typeno

platformyesyes





Tumor TypetumorTypeyesThe text term used to describe the type of malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Acinar Cell Neoplasms
  • Adenomas and Adenocarcinomas
  • Adnexal and Skin Appendage Neoplasms
  • Basal Cell Neoplasms
  • Blood Vessel Tumors
case/disease_typeyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




SitesiteNAnoThe text term used to describe the general location of the malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Accessory sinuses
  • Adrenal gland
  • Anus and anal canal
  • Base of tongue
  • Bladder
case/primary_siteyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




EthnicityethnicityNAnoAn individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.
  • hispanic or latino
  • not hispanic or latino
  • Unknown
  • not reported
  • not allowed to collect
demographic/ethnicityyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




genderGendersexyesText designations that identify gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles. [Explanatory Comment 1: Identification of gender is based upon self-report and may come from a form, questionnaire, interview, etc.]
  • female
  • male
  • unknown
  • unspecified
  • not reported
demographic/genderyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




RaceNAnoAn arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.
  • white
  • american indian or alaska native
  • black or african american
  • asian
  • native hawaiian or other pacific
demographic/raceyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




Tissuetissue_or_organ_of_originyesThe text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdomen, NOS
  • Abdominal esophagus
  • Accessory sinus, NOS
  • Acoustic nerve
  • Adrenal gland, NOS
diagnosis/tissue_or_organ_of_originyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosisage_at_diagnosisAge at the time of diagnosis expressed in number of days since birth.diagnosis/age_at_diagnosisyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosisdays_to_last_follow_upTime interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days.diagnosis/days_to_last_follow_upnohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosisdays_to_last_known_disease_statusTime interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days.




diagnosis/days_to_last_known_disease_statusnohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosisdays_to_recurrenceNumber of days between the date used for index and the date the patient's disease recurred.diagnosis/days_to_recurrencenohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosislast_known_disease_statusText term that describes the last known state or condition of an individual's neoplasm.
  • Distant met recurrence/progression
  • Loco-regional recurrence/progression
  • Biochemical evidence of disease without structural correlate
  • Tumor free
diagnosis/last_known_disease_statusnoGrantcenterNameyes










Grant TypegrantTypeyes
U54 or U01








Consortiumconsortiumyes
CSBC or PSON








AgeNAno

diagnosis/age_at_diagnosisyes??https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosismorphologyThe third edition of the International Classification of Diseases for Oncology, published in 2000 used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms. The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs. In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains. A system of numbered categories for representation of data.diagnosis/morphologynohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




primary_diagnosisPrimary DiagnosisNAnoText term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdominal desmoid
  • Abdominal fibromatosis
  • Achromic nevus
  • Acidophil adenocarcinoma
  • Acidophil adenoma
diagnosis/primary_diagnosisnonohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosisprogression_or_recurrence




ProgressionNAnoYes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.
  • yes
  • no
  • unknown
  • not reported
  • Not Allowed To Collect
diagnosis/progression_or_recurrencenohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosissite_of_resection_or_biopsyThe text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdomen, NOS
  • Abdominal esophagus
  • Accessory sinus, NOS
  • Acoustic nerve
  • Adrenal gland, NOS
diagnosis/site_of_resection_or_biopsynohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosistumor_gradeNumeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.
  • G1
  • G2
  • G3
  • G4
  • GX
diagnosis/tumor_gradenohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




tumor_stageThe extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body. The accepted values for tumor_stage depend on the tumor site, type, and accepted staging system. These items should accompany the tumor_stage value as associated metadata.diagnosis/tumor_stagenohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosisvital_statusVital StatusNAnoThe survival state of the person registered on the protocol.
  • alive
  • dead
  • lost to follow-up
  • unknown
  • not reported
diagnosis/vital_statusyes??https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Sample TypeNAnoText term to describe the source of a biospecimen used for a laboratory test.
  • Additional Metastatic
  • Additional - New Primary
  • Blood Derived Cancer - Bone Marrow, Post-treatment
  • Blood Derived Cancer - Peripheral Blood, Post-treatment
  • Blood Derived Normal
  • Bone Marrow Normal
  • Buccal Cell Normal
  • Cell Line Derived Xenograft Tissue
  • Cell Lines
sample/sample_typenoyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=sampletissue_type




Tissue TypeNAnoText term that represents a description of the kind of tissue collected with respect to disease status or proximity to tumor tissue.
  • Tumor
  • Normal
  • Abnormal
  • Peritumoral
  • Unknown
sample/tissue_typenoyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=sample




...

GDC Data Dictionary is implemented in YAML files: https://github.com/NCI-GDC/gdcdictionary

GDC submission process (and metadata templates) are described here: https://docs.gdc.cancer.gov/Data_Submission_Portal/Users_Guide/Data_Submission_Overview/

GDC Data Upload Walkthrough: https://docs.gdc.cancer.gov/Data_Submission_Portal/Users_Guide/Data_Submission_Walkthrough/#clinical-data-requirements